Literature DB >> 24144458

The role of abdominal ultrasound in the diagnosis of typhoid fever: an observational study.

Saeed Nadhim Younis1.   

Abstract

OBJECTIVES: To study the usefulness of abdominal ultrasound in the diagnosis of typhoid fever and to determine the common ultrasound findings early in the course of the disease.
METHODS: Abdominal ultrasound examination was performed within the first week of initiation of symptoms in 350 cases with clinical diagnosis of typhoid fever. Subsequent ultrasound follow-up examination was done 15 days later (beginning of the third week). All the patients proved to have positive Widal test and Sallmonella culture. The study was performed in Erbil-Iraq from the period January 1993 to October 2010.
RESULTS: The following ultrasound findings were reported: hepatomegaly (31.4%), prominent intrahepatic bile ducts (64.85%), splenomegaly (100%), mesenteric lymphadenopathy (42.85%), bowel wall thickening (35.71%), acalculous cholecystitis (16.28%), perforations (1.14%), and ascites in (3.4%).
CONCLUSION: The current study showed that the findings are typical enough to justify initiation of treatment for typhoid fever when serology is equivocal and culture is negative, and is fairly safe to say that normal ultrasound examination early in the course of febrile illness rules out typhoid fever.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Salmonellosis; Typhoid fever; Ultrasound

Mesh:

Year:  2013        PMID: 24144458     DOI: 10.1016/j.tmaid.2013.09.004

Source DB:  PubMed          Journal:  Travel Med Infect Dis        ISSN: 1477-8939            Impact factor:   6.211


  2 in total

1.  Transient periportal hyperechogenicity in feverish patients: a novel ultrasonographic finding.

Authors:  Muhammad Abd El-Gawad Shawky; Ahmed Samir Abd Eltawab; Ahmed Abd-Elrady Ahmed
Journal:  J Ultrasound       Date:  2019-03-06

2.  Typhoid intestinal perforation in developing countries: Still unavoidable deaths?

Authors:  Sandro Contini
Journal:  World J Gastroenterol       Date:  2017-03-21       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.